A Rare Case of Giant Rhinophyma
DOI:
https://doi.org/10.66344/jpad.v32i1.1826Abstract
Rhinophyma is a rare skin disease characterized by a disfiguring enlargement of the nose due to hyperplasia of sebaceous glands and underlying connective tissue. It is generally considered to be a final stage of untreated rosacea. This report describes a 79-year-old man manifested with a giant rinophyma measuring 7 cm in diameter. It grew for many years but the patient had not sought any dermatologic intervention. The lesion was completely removed by using sharp scalpel incision. Although rhinophyma is not a life-threatening condition, it can sometimes reach a huge size, with a negative effect on quality of life. Such cases are usually a consequence of patient's delay in seeking medical advice. In more pronounced lesions, a simple surgical removal under tumescent anestesia is an optimal treatment modality.
References
1. Zubair S, Mujtaba G. Brimonidine tartrate 0.1% eyedrops new and effective treatment of rosacea. J Pak Assoc Dermatol. 2014;24:332-6.
2. Chauhan R, Loewenstein SN, Hassanein A. Rhinophyma: prevalence, severity, impact and management. Clin Cosmet Investig Dermatol. 2020;13:537-51.
3. Laun J, Gopman J, Elston JB, Harrington MA. Rhinophyma. Eplasty 2015,15:ic25.
4. Schüürmann M, Wetzig T, Wickenhauser T, et al. Histopathology of rhinophyma: a clinical-histopathologic correlation. J Cutan Pathol. 2015;42:527-35.
5. Wetzig T, Averbeck M, Simon JC, Kendler M. New rhinophyma severity index and mid-term results following shave excision of rhinophyma. Dermatology. 2013;227:31-3.
6. Sibenge S, Gawkrodger DJ. Rosacfea: A study of clinical patterns, blood flow and the role of Demodex folliculorum. J Am Acad Dermatol. 1992;26:590-3.
7. Kavoussi H, Ramazani M, Ebrahimi A. Nasal deformity accompanying upper lip sebaceous carcinoma without neoplasm extension. J Pak Assoc Dermatol. 2012;22:70-2.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Vladimír Bartoš
This work is licensed under a Creative Commons Attribution 4.0 International License.
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.
